✦ LIBER ✦

Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors

✍ Scribed by John Araujo; Christopher Logothetis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

383 POSTER A Phase I Study of dasatinib,

✍ J. Morgan; G. Demetri; D. Wang; I. MacPherson; P. LoRusso; A. van den Abbeele; V 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Discovery of a Highly Potent, Orally Act

✍ Liu, Jin-Jun; Higgins, Brian; Ju, Grace; Kolinsky, Kenneth; Luk, Kin-Chun; Packm 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 305 KB

Combretastatin A-4 and hyperthermia;a po

✍ Hans P Eikesdal; Rolf Bjerkvig; Olav Mella; Olav Dahl 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 518 KB

CDK inhibitors in clinical development f

✍ Fischer, Peter M; Gianella-Borradori, Athos 📂 Article 📅 2003 🏛 Informa plc 🌐 English ⚖ 450 KB

Small Molecule Tyrosine Kinase Inhibitor

✍ Neeltje Steeghs; Johan W. R. Nortier; Hans Gelderblom 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 311 KB

Effects of treatment with histone deacet

✍ Qiu, Tianzhu (author);Zhou, Li (author);Zhu, Wei (author);Wang, Tongshan (author 📂 Article 📅 2013 🏛 Future Medicine 🌐 English ⚖ 798 KB